Mercury induces an unopposed inflammatory response in human peripheral blood mononuclear cells in vitro

Environmental Health Perspectives

Volumn 117, Issue 12, 2009, Pages 1932-1938

  Gardner, Renee M ^a   Nyland, Jennifer F ^a,b   Evans, Sean L ^a   Wang, Susie B ^a   Doyle, Kathleen M ^a   Crainiceanu, Ciprian M ^a   Silbergeld, Ellen K ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Immunotoxicity; Inflammation; Mercury; Multilevel modeling

Indexed keywords

ACEBUTOLOL; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MERCURIC CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CONCENTRATION RESPONSE; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; INFLAMMATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERNATANT;

ADULT; BLOOD DONORS; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MERCURY;

ANIMALIA;

EID: 75349084776     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900855     Document Type: Article

References (42)

1. Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, DePierre JW, Hassan M. 2005. Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice. Clin Exp Immunol 141(2):238-247.
2. Alves MF, Fraiji NA, Barbosa AC, De Lima DS, Souza JR, Dorea JG, et al. 2006. Fish consumption, mercury exposure and serum antinuclear antibody in Amazonians. Int J Environ Health Res 16(4):255-262.
3. Apostolakis S, Vogiatzi K, Krambovitis E, Spandidos DA. 2008. IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications. Cardiovasc Hematol Agents Med Chem 6(2):150-158.
4. Arend WP. 2002. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13(4-5):323-340.
5. Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, et al. 1996. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immuno genetic, serologic, and clinical analysis. Arthritis Rheum 39(7):1151-1160.
6. Bagenstose LM, Salgame P, Monestier M. 1998. Mercury-induced autoimmunity in the absence of IL-4. Clin Exp Immunol 114(1):9-12.
7. Bagenstose LM, Salgame P, Monestier M. 1999. Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. Environ Health Perspect 107(suppl 5):807-810.
8. Barregard L, Enestrom S, Ljunghusen O, Wieslander J, Hultman P. 1997. A study of autoantibodies and circulating immune complexes in mercury-exposed chloralkali workers. Int Arch Occup Environ Health 70(2):101-106.
9. Boyle JJ. 2005. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3(1):63-68.
10. Chaudhary A, Sauer NN, Gupta G. 2004. Beryllium-specific immune response in primary cells from healthy individuals. Toxicology 201(1-3):9-19.
11. Cooke A, Ferraccioli GF, Herrmann M, Romani L, Schulze C, Zampieri S, et al. 2008. Induction and protection of autoimmune rheumatic diseases. The role of infections. Clin Exp Rheumatol 26(1 suppl 48):S1-S7.
12. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. 2004. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 31(10):1928-1933.
13. Coury F, Ferraro-Peyret C, Le Cam S, Guerin S, Tebib J, Sibilia J, et al. 2008. Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy. Clin Exp Rheumatol 26(2):234-239.
14. Crainiceanu CM, Ruppert D, Wand MP. 2005. Bayesian analysis for penalized spline regression using WinBUGS. J Stat Software 14(14):1-24.
15. Crompton P, Ventura AM, de Souza JM, Santos E, Strickland GT, Silbergeld E. 2002. Assessment of mercury exposure and malaria in a Brazilian Amazon riverine community. Environ Res 90(2):69-75.
16. Ellingsen DG, Efskind J, Berg KJ, Gaarder PI, Thomassen Y. 2000. Renal and immunologic markers for chloralkali workers with low exposure to mercury vapor. Scand J Work Environ Health 26(5):427-435.
17. Fairweather D, Frisancho-Kiss S, Rose NR. 2008. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 173(3):600-609.
18. Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Barrett MA, et al. 2007. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178(11):6710-6714.
19. Garner-Spitzer E, Kundi M, Rendi-Wagner P, Winkler B, Wiedermann G, Holzmann H, et al. 2008. Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees. Vaccine 27(2):197-204.
20. Giese C, Demmler CD, Ammer R, Hartmann S, Lubitz A, Miller L, et al. 2006. A human lymph node in vitro - challenges and progress. Artif Organs 30(10):803-808.
21. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, Gomez-Aracena J, et al. 2002. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347(22):1747-1754.
22. Haggqvist B, Hultman P. 2003. Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response. Clin Exp Immunol 134(2):202-209.
23. Haggqvist B, Hultman P. 2005. Interleukin-10 in murine metal-induced systemic autoimmunity. Clin Exp Immunol 141(3):422-431.
24. Havarinasab S, Bjorn E, Nielsen JB, Hultman P. 2007. Mercury species in lymphoid and non-lymphoid tissues after exposure to methyl mercury: correlation with autoimmune parameters during and after treatment in susceptible mice. Toxicol Appl Pharmacol 221(1):21-28.
25. Havarinasab S, Hultman P. 2005. Organic mercury compounds and autoimmunity. Autoimmun Rev 4(5):270-275.
26. Hightower JM, Moore D. 2003. Mercury levels in high-end consumers of fish. Environ Health Perspect 111:604-608.
27. Hill AV. 2006. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 40:469-486.
28. Hoffmann S, Peterbauer A, Schindler S, Fennrich S, Poole S, Mistry Y, et al. 2005. International validation of novel pyrogen tests based on human monocytoid cells. J Immunol Methods 298(1-2):161-173.
29. Hu H, Moller G, Abedi-Valugerdi M. 1999. Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunology 96(3):348-357.
30. Klein SL. 2000. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 24(6):627-638.
31. Love OP, Salvante KG, Dale J, Williams TD. 2008. Sex-specific variability in the immune system across life-history stages. Am Nat 172(3):E99-E112.
32. Lunn DJ, Thomas A, Best N, Spiegelhalter D. 2000. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comp 10(4):325-337.
33. National Research Council. 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC:National Academy Press.
34. National Research Council. 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC:National Academies Press.
35. R Foundation for Statistical Computing. 2008. R Project for Statistical Computing. Available: http://www.r-project.org/ [accessed 3 November 2009].
36. Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, et al. 2006. Proinflammatory cytokines (TNF-αand IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 35(3-4):148-153.
37. Silbergeld EK, Silva IA, Nyland JF. 2005. Mercury and auto immunity: implications for occupational and environmental health. Toxicol Appl Pharmacol 207(2 suppl):282-292.
38. Silva IA, Nyland JF, Gorman A, Perisse A, Ventura AM, Santos EC, et al. 2004. Mercury exposure, malaria, and serum antinuclear/ antinucleolar antibodies in Amazon popu lations in Brazil: a cross-sectional study. Environ Health 3(1):11; doi:10.1186/1476-069X-3-11 [Online 2 November 2004].
39. Suda I, Totoki S, Uchida T, Takahashi H. 1992. Degradation of methyl and ethyl mercury into inorganic mercury by various phagocytic cells. Arch Toxicol 66(1):40-44.
40. Suh CH, Kim HA. 2008. Cytokines and their receptors as biomarkers of systemic lupus erythematosus. Expert Rev Mol Diagn 8(2):189-198.
41. Vahter M, Mottet NK, Friberg L, Lind B, Shen DD, Burbacher T. 1994. Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol Appl Pharmacol 124(2):221-229.
42. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8(9):950-957.